ONLINE DATABASE SEARCH - OI-LS-341-MEMO
1. 48455 OI-LS-341; SCIFINDER-OI-1/31/2006
CryptoDB: a Cryptosporidium bioinformatics resource update
Heiges, Mark, Wang, Haiming, Robinson, Edward, Aurrecoechea, Cristina, Gao, Xin, Kaluskar, Nivedita, Rhodes, Philippa, Wang, Sammy, He, Cong-Zhou, Su, Yanqi, Miller, John, Kraemer, Eileen, and Kissinger, Jessica C
Nucleic Acids Research 2006. 34(Supplement1): D419-D422
2. 48456 OI-LS-341; PUBMED-OI-2/6/2006
Synthesis and antiviral activity of some 2-substituted 3-formyl- and 3-cyano-5,6-dichloroindole nucleosides
Williams, JD, Drach, JC, and Townsend, LB
Nucleosides Nucleotides Nucleic Acids 2005. 24(10-12): 1613-26
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16438038&dopt=abstract
3. 48457 OI-LS-341; SCIFINDER-OI-1/31/2006
Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum
Baramee, Apiwat, Coppin, Alexandra, Mortuaire, Marlene, Pelinski, Lydie, Tomavo, Stanislas, and Brocard, Jacques
Bioorganic & Medicinal Chemistry 2006. 14(5): 1294-1302
4. 48458 OI-LS-341; SCIFINDER-OI-1/31/2006
Lipid biology of Apicomplexa: perspectives for new drug targets, particularly for Toxoplasma gondii
Sonda, Sabrina and Hehl, Adrian B
Trends in Parasitology 2006. 22(1): 41-47
5. 48459 OI-LS-341; WOS-OI-1/29/2006
Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase
Giuliano, C, Fiore, F, Di, Marco A, Velazquez, JP, Bishop, A, Bonelli, F, Gonzalez-Paz, O, Marcucci, I, Harper, S, Narjes, F, Pacini, B, Monteagudo, E, Migliaccio, G, Rowley, M, and Laufer, R
XENOBIOTICA 2005. 35(10-11): 1035-1054, 20
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234427600008
6. 48460 OI-LS-341; SCIFINDER-OI-1/31/2006
Purification and characterization of the Mycobacterium tuberculosis FabD2, a novel malonyl-CoA:AcpM transacylase of fatty acid synthase
Huang, Yi-Shu, Ge, Jing, Zhang, Hong-Mei, Lei, Jian-Qiang, Zhang, Xue-Lian, and Wang, Hong-Hai
Protein Expression and Purification 2006. 45(2): 393-399
7. 48461 OI-LS-341; WOS-OI-1/29/2006
Specific molecular mechanisms involved in the antiviral response to murine cytomegalovirus
Sumaria, N, Van Dommelen, S, Smyth, M, and Degli-Esposti, M
TISSUE ANTIGENS 2005. 66(5): 555-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000233542700580
8. 48462 OI-LS-341; SCIFINDER-OI-1/31/2006
3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods
Aparna, V, Jeevan, J, Ravi, M, Desiraju, GR, and Gopalakrishnan, B
Bioorganic & Medicinal Chemistry Letters 2006. 16(4): 1014-1020
9. 48463 OI-LS-341; SCIFINDER-OI-1/31/2006
Developing an Antituberculosis Compounds Database and Data Mining in the Search of a Motif Responsible for the Activity of a Diverse Class of Antituberculosis Agents
Prakash, Om and Ghosh, Indira
Journal of Chemical Information and Modeling 2006. 46(1): 17-23
10. 48464 OI-LS-341; WOS-OI-1/29/2006
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
Manjunatha, UH, Boshoff, H, Dowd, CS, Zhang, L, Albert, TJ, Norton, JE, Daniels, L, Dickl, T, Pang, SS, and Barry, CE
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2006. 103(2): 431-436, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234624100033
11. 48465 OI-LS-341; SCIFINDER-OI-1/31/2006
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes
Aubry, Alexandra, Veziris, Nicolas, Cambau, Emmanuelle, Truffot-Pernot, Chantal, Jarlier, Vincent, and Fisher, LMark
Antimicrobial Agents and Chemotherapy 2006. 50(1): 104-112
12. 48466 OI-LS-341; SCIFINDER-OI-1/31/2006
Substituted quinolones
Schohe-Loop, Rudolf, Zimmermann, Holger, Henninger, Kerstin, Paulsen, Daniela, Roelle, Thomas, Lang, Dieter, Thede, Kai, Fuerstner, Chantal, Brueckner, David, Koebberling, Johannes, and Bauser, Marcus
PATENT: WO 2006008046 ISSUE DATE: 20060126
APPLICATION: 2005 PP: 115 pp.
ASSIGNEE: (Bayer Healthcare AG, Germany
13. 48467 OI-LS-341; SCIFINDER-OI-1/31/2006
Synthesis, antiviral, and antitumor activity of 2-substituted purine methylenecyclopropane analogues of nucleosides
Qin, Xinrong, Chen, Xinchao, Wang, Kun, Polin, Lisa, Kern, Earl R, Drach, John C, Gullen, Elizabeth, Cheng, Yung-Chi, and Zemlicka, Jiri
Bioorganic & Medicinal Chemistry 2006. 14(4): 1247-1254
14. 48468 OI-LS-341; SCIFINDER-OI-1/31/2006
Anti-viral uses of borinic acid complexes
Bellinger-Kawahara, Carolyn, Maples, Kirk R, and Plattner, Jacob J
PATENT: US 2006019927 ISSUE DATE: 20060126
APPLICATION: 2005-21887 PP: 20 pp.
ASSIGNEE: (USA)
15. 48469 OI-LS-341; SCIFINDER-OI-1/31/2006
Imidazole and thiazole derivatives as antiviral agents
Conte, Immacolata, Hernando, Jose Ignacio Martin, Malancona, Savina, Ontoria Ontoria, Jesus Maria, and Stansfield, Ian
PATENT: WO 2006008556 ISSUE DATE: 20060126
APPLICATION: 2005 PP: 34 pp.
ASSIGNEE: (Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA, Italy
16. 48470 OI-LS-341; SCIFINDER-OI-1/31/2006
The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practice
McHutchison, John G, Bartenschlager, Ralf, Patel, Keyur, and Pawlotsky, Jean-Michel
Journal of Hepatology 2006. 44(2): 411-421
17. 48471 OI-LS-341; SCIFINDER-OI-1/31/2006
Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy
De Clercq, Erik and Field, Hugh J
British Journal of Pharmacology 2006. 147(1): 1-11
18. 48472 OI-LS-341; SCIFINDER-OI-1/31/2006
Preparation of 5-aza-7-deazadeazapurine and C-branched nucleosides as antiviral agents for treating Flaviviridae
Gosselin, Gilles, La Colla, Paolo, Seela, Frank, Storer, Richard, Dukhan, David, and Leroy, Frederic
PATENT: WO 2006000922 ISSUE DATE: 20060105
APPLICATION: 2005 PP: 115 pp.
ASSIGNEE: (Idenix (Cayman) Limited, Cayman I.
19. 48473 OI-LS-341; WOS-OI-1/29/2006
Antioxidant and antimycobacterial activities of Tabernaemontana catharinensis extracts obtained by supercritical CO2 + cosolvent
Pereira, CG, Leal, PF, Sato, DN, and Meireles, MAA
JOURNAL OF MEDICINAL FOOD 2005. 8(4): 533-538, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234554400019
20. 48474 OI-LS-341; SCIFINDER-OI-1/31/2006
Preparation of aza nucleoside analogs and their use as antiviral agents and inhibiting viral RNA polymerases
Babu, Yarlagadda S, Chand, Pooran, Ghosh, Ajit K, Kotian, Pravin L, and Kumar, Satish V
PATENT: WO 2006002231 ISSUE DATE: 20060105
APPLICATION: 2005 PP: 75 pp.
ASSIGNEE: (Biocryst Pharmaceuticals, Inc. USA
21. 48475 OI-LS-341; WOS-OI-1/29/2006
Synthesis and biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one base and nucleoside derivatives
Robins, MJ, Miranda, K, Rajwanshi, VK, Peterson, MA, Andrei, G, Snoeck, R, De, Clercq E, and Balzarini, J
JOURNAL OF MEDICINAL CHEMISTRY 2006. 49(1): 391-398, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234575300040
22. 48476 OI-LS-341; WOS-OI-1/29/2006
Diagnosis and therapy in the field of hepatology - 2005 Hepatitis C: From discovery of the virus to individualized therapy
Manns, MP
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 2005. 130: S197-+, 49
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234378300001
23. 48477 OI-LS-341; WOS-OI-1/29/2006
A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b : 2b replicon containing a genotype 1b NS3-5A background
Graham, DJ, Stahlhut, M, Flores, O, Olsen, DB, Hazuda, DJ, LaFemina, RL, and Ludmerer, SW
ANTIVIRAL RESEARCH 2006. 69(1): 24-30, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234525900003
24. 48478 OI-LS-341; WOS-OI-2/5/2006
Quantitative proteomic analysis of drug-induced changes in mycobacteria
Hughes, MA, Silva, JC, Geromanos, SJ, and Townsend, CA
JOURNAL OF PROTEOME RESEARCH 2006. 5(1): 54-63, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234668300005
25. 48479 OI-LS-341; WOS-OI-2/5/2006
The potential impact of structural genomics on tuberculosis drug discovery
Arcus, VL, Lott, JS, Johnston, JM, and Baker, EN
DRUG DISCOVERY TODAY 2006. 11(1-2): 28-34, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234823500005
26. 48480 OI-LS-341; WOS-OI-2/5/2006
Synthesis and biological evaluation of novel benzimidazol/benzoxazolylethoxypiperidone oximes
Balasubramanian, S, Aridoss, G, Parthiban, P, Ramalingan, C, and Kabilan, S
BIOLOGICAL & PHARMACEUTICAL BULLETIN 2006. 29(1): 125-130, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234760200026
27. 48481 OI-LS-341; WOS-OI-2/5/2006
Establishment of stable HeLa cell lines expressing enzymatically active hepatitis C virus RNA polymerase
Kong, LB, Ye, LB, Ye, L, Timani, KA, Zheng, Y, Liao, QJ, Li, BZ, and Gao, B
ARCHIVES OF VIROLOGY 2006. 151(2): 361-367, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234807300012